Inpatient Distress Tolerance Group Intervention Pilot
A Transdiagnostic Group Intervention to Enhance Distress Tolerance: A Mixed Methods Pilot Evaluation in an Acute Inpatient Setting
1 other identifier
interventional
21
1 country
1
Brief Summary
Research suggests that a low capacity to tolerate distress is a common underlying factor in the development and maintenance of a range of mental health problems. This study aims to pilot a mindfulness-based distress tolerance (DT) group intervention in an acute inpatient setting to assess the acceptability and feasibility of the intervention for both staff facilitating and patients receiving the intervention. The study also aims to explore if the proposed intervention can help improve DT through developing mindful acceptance of emotions.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Feb 2019
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 16, 2018
CompletedFirst Posted
Study publicly available on registry
October 19, 2018
CompletedStudy Start
First participant enrolled
February 18, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2020
CompletedApril 28, 2021
April 1, 2021
1.9 years
October 16, 2018
April 27, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Acceptability and Feasibility Qualitative Interview
A semi-structured face to face interview to gather information about participants experiences of the intervention.
Post Intervention (Start of week 5)
Attendance/Attrition Rates
Attendance/attrition rates as a measure of how acceptable/feasible the intervention is to participants.
twice a week at each group session for up to three weeks
Secondary Outcomes (7)
Distress Tolerance Scale (Simons & Gaher, 2005)
Pre-intervention (day 0), every day during baseline (days 1-7), every day for up to three weeks during intervention (days 8-28), and post-intervention (Start of week 5)
Computerised Mirror tracing persistence task (MTPT-C; Strong et al., 2003)
Pre intervention meeting (day 0) and Post intervention (usually start of week 5)
Philadelphia Mindfulness Scale - acceptance subscale (PHLMS; Cardaciotto et al., 2008)
Pre-intervention (day 0), every day during baseline (days 1-7), every day for up to three weeks during intervention (days 8-28), and post-intervention (Start of week 5)
The clinical Outcome in Routine Evaluation Outcome Measure (CORE-OM, Evans et al., 2002).
Pre intervention (day 0) and post intervention (usually start of week 5)
Clinical Outcomes in Routine Evaluation Questionnaire (CORE-10; Connell & Barkham, 2007).
Every day during baseline (days 1-7) and every day for up to three weeks during intervention (days 8-28)
- +2 more secondary outcomes
Study Arms (1)
Distress Tolerance Group
EXPERIMENTAL6 session inpatient distress tolerance group intervention twice a week for 1.5 hours for up to three weeks.
Interventions
The intervention is a distress tolerance skills-based group informed by mindfulness and acceptance principles and dialectical behavioural therapy (DBT).
Eligibility Criteria
You may qualify if:
- Current in-patient in the specific psychiatric ward in which the research is taking place
- Speak sufficient English to participate in talking therapy
You may not qualify if:
- Participants who are participating in any other current intervention research
- Participants who do not have the capacity to consent, including participants who have a significant cognitive deficit that would make it difficult for them to engage with the group material (e.g. dementia or learning disability)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Edinburghlead
- NHS Lanarkshirecollaborator
Study Sites (1)
Hairmyres Hospital
East Kilbride, South Lanarkshire, G75 8RG, United Kingdom
Study Officials
- PRINCIPAL INVESTIGATOR
Emma L Boyd
NHS Lanarkshire
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 16, 2018
First Posted
October 19, 2018
Study Start
February 18, 2019
Primary Completion
December 31, 2020
Study Completion
December 31, 2020
Last Updated
April 28, 2021
Record last verified: 2021-04
Data Sharing
- IPD Sharing
- Will not share